175 related articles for article (PubMed ID: 32151211)
1. Drug treatment strategies for osteoporosis in stroke patients.
Hsieh CY; Sung SF; Huang HK
Expert Opin Pharmacother; 2020 May; 21(7):811-821. PubMed ID: 32151211
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
3. Potential of alfacalcidol for reducing increased risk of falls and fractures.
Ringe JD; Schacht E
Rheumatol Int; 2009 Aug; 29(10):1177-85. PubMed ID: 19159932
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis.
Avenell A; Gillespie WJ; Gillespie LD; O'Connell D
Cochrane Database Syst Rev; 2009 Apr; (2):CD000227. PubMed ID: 19370554
[TBL] [Abstract][Full Text] [Related]
5. Fracture Prevention with Zoledronate in Older Women with Osteopenia.
Reid IR; Horne AM; Mihov B; Stewart A; Garratt E; Wong S; Wiessing KR; Bolland MJ; Bastin S; Gamble GD
N Engl J Med; 2018 Dec; 379(25):2407-2416. PubMed ID: 30575489
[TBL] [Abstract][Full Text] [Related]
6. Acute and long-term effects of zoledronate in adult patients with osteogenesis imperfecta. An observational Spanish study with five years of follow-up.
Pavón de Paz I; Rosado Sierra JA; Pérez Blanco C; Modroño Móstoles N; Guijarro de Armas G; Navea Aguilera C
Endocrinol Diabetes Nutr (Engl Ed); 2019 Feb; 66(2):108-116. PubMed ID: 30077631
[TBL] [Abstract][Full Text] [Related]
7. Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis.
Vestergaard P; Jorgensen NR; Mosekilde L; Schwarz P
Osteoporos Int; 2007 Jan; 18(1):45-57. PubMed ID: 16951908
[TBL] [Abstract][Full Text] [Related]
8. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
Mori Y; Kasai H; Ose A; Serada M; Ishiguro M; Shiraki M; Tanigawara Y
Osteoporos Int; 2018 May; 29(5):1155-1163. PubMed ID: 29423715
[TBL] [Abstract][Full Text] [Related]
9. Successful direct intervention for osteoporosis in patients with minimal trauma fractures.
Kuo I; Ong C; Simmons L; Bliuc D; Eisman J; Center J
Osteoporos Int; 2007 Dec; 18(12):1633-9. PubMed ID: 17603741
[TBL] [Abstract][Full Text] [Related]
10. Management of osteoporosis in rheumatoid arthritis patients.
Hoes JN; Bultink IE; Lems WF
Expert Opin Pharmacother; 2015 Mar; 16(4):559-71. PubMed ID: 25626121
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study.
Ringe JD; Faber H; Farahmand P; Dorst A
Rheumatol Int; 2006 Mar; 26(5):427-31. PubMed ID: 16001181
[TBL] [Abstract][Full Text] [Related]
12. Changes in blood and urinary cadmium levels and bone mineral density according to osteoporosis medication in individuals with an increased cadmium body burden.
Eom SY; Yim DH; Hong SM; Kim YD; Kim H; Choi BS; Park JD; Park CH; Kim GB; Yu SD
Hum Exp Toxicol; 2018 Apr; 37(4):350-357. PubMed ID: 28441892
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates for osteoporosis in people with cystic fibrosis.
Conwell LS; Chang AB
Cochrane Database Syst Rev; 2012 Apr; (4):CD002010. PubMed ID: 22513903
[TBL] [Abstract][Full Text] [Related]
14. Combination and sequential treatment in women with postmenopausal osteoporosis.
Anastasilakis AD; Polyzos SA; Yavropoulou MP; Makras P
Expert Opin Pharmacother; 2020 Mar; 21(4):477-490. PubMed ID: 31990595
[No Abstract] [Full Text] [Related]
15. Efficiency of Zoledronic Acid in Inhibiting Accelerated Periprosthetic Bone Loss After Cementless Total Hip Arthroplasty in Osteoporotic Patients: A Prospective, Cohort Study.
Fu GT; Lin LJ; Sheng PY; Li CC; Zhang JX; Shen J; Liu S; Xue YL; Lin SP; Wang K; Zheng QJ; Ding Y
Orthop Surg; 2019 Aug; 11(4):653-663. PubMed ID: 31456320
[TBL] [Abstract][Full Text] [Related]
16. Osteoporosis: trials and tribulations.
Seeman E
Am J Med; 1997 Aug; 103(2A):74S-87S; discussion 87S-89S. PubMed ID: 9302899
[TBL] [Abstract][Full Text] [Related]
17. Osteoporosis - pharmacological prevention and management in older people.
Bell JS; Blacker N; Edwards S; Frank O; Alderman CP; Karan L; Husband A; Rowett D
Aust Fam Physician; 2012 Mar; 41(3):110-8. PubMed ID: 22396923
[TBL] [Abstract][Full Text] [Related]
18. Interventions for the treatment of decreased bone mineral density associated with HIV infection.
Lin D; Rieder MJ
Cochrane Database Syst Rev; 2007 Apr; (2):CD005645. PubMed ID: 17443607
[TBL] [Abstract][Full Text] [Related]
19. Updated approach for the management of osteoporosis in Turkey: a consensus report.
Kirazlı Y; Atamaz Çalış F; El Ö; Gökçe Kutsal Y; Peker Ö; Sindel D; Tuzun Ş; Gogas Yavuz D; Durmaz B; Akarirmak Ü; Bodur H; Hamuryudan V; Inceboz U; Öncel S
Arch Osteoporos; 2020 Aug; 15(1):137. PubMed ID: 32860546
[TBL] [Abstract][Full Text] [Related]
20. Calcium and vitamin D for osteoporotic fracture prevention.
Carmona RJ; Adachi JD
Pol Arch Med Wewn; 2007 Oct; 117(10):441-2. PubMed ID: 18320782
[No Abstract] [Full Text] [Related]
[Next] [New Search]
